{"entity":{"type":"insider","cik":"0001914448","url":"/insider/0001914448","json_url":"/insider/0001914448.json","name":"Clark Eliana","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":11,"first":"2023-01-06","last":"2026-03-03","span_basis":"filed_date"},"name_variants":[{"name":"Clark Eliana","source":"filing","n_filings":11,"first_seen":"2023-01-06","last_seen":"2026-03-03"}],"transactions":[{"id":5870437,"accession":"0001193125-26-088241","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-088241","line_url":"/filing/0001193125-26-088241#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":607.0,"shares_display":"607","price_per_share":13.78,"price_display":"13.78","price_state":"stated","total_value":8364.46,"total_display":"8,364.46","total_whole":"8,364","shares_owned_after":93864.0,"shares_owned_after_display":"93,864","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-03","scope":"insider"},{"id":5978129,"accession":"0001193125-26-006278","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-006278","line_url":"/filing/0001193125-26-006278#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9515.0,"shares_display":"9,515","price_per_share":9.21,"price_display":"9.21","price_state":"stated","total_value":87633.15,"total_display":"87,633.15","total_whole":"87,633","shares_owned_after":87118.0,"shares_owned_after_display":"87,118","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-05","filed_date":"2026-01-07","scope":"insider"},{"id":4497036,"accession":"0000950170-25-093852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-093852","line_url":"/filing/0000950170-25-093852#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1022.0,"shares_display":"1,022","price_per_share":9.82,"price_display":"9.82","price_state":"stated","total_value":10036.04,"total_display":"10,036.04","total_whole":"10,036","shares_owned_after":95369.0,"shares_owned_after_display":"95,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-01","filed_date":"2025-07-03","scope":"insider"},{"id":4234623,"accession":"0000950170-25-032263","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-032263","line_url":"/filing/0000950170-25-032263#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":679.0,"shares_display":"679","price_per_share":8.99,"price_display":"8.99","price_state":"stated","total_value":6104.21,"total_display":"6,104.21","total_whole":"6,104","shares_owned_after":95369.0,"shares_owned_after_display":"95,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-04","filed_date":"2025-03-04","scope":"insider"},{"id":4375424,"accession":"0000950170-25-002115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-002115","line_url":"/filing/0000950170-25-002115#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7422.0,"shares_display":"7,422","price_per_share":12.18,"price_display":"12.18","price_state":"stated","total_value":90399.96,"total_display":"90,399.96","total_whole":"90,400","shares_owned_after":64048.0,"shares_owned_after_display":"64,048","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-03","filed_date":"2025-01-06","scope":"insider"},{"id":4375419,"accession":"0000950170-25-002115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-002115","line_url":"/filing/0000950170-25-002115#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":556.0,"shares_display":"556","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":6688.68,"total_display":"6,688.68","total_whole":"6,689","shares_owned_after":71470.0,"shares_owned_after_display":"71,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-02","filed_date":"2025-01-06","scope":"insider"},{"id":2515487,"accession":"0000950170-24-081259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-081259","line_url":"/filing/0000950170-24-081259#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":405.0,"shares_display":"405","price_per_share":22.93,"price_display":"22.93","price_state":"stated","total_value":9286.65,"total_display":"9,286.65","total_whole":"9,287","shares_owned_after":71470.0,"shares_owned_after_display":"71,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-01","filed_date":"2024-07-03","scope":"insider"},{"id":2849609,"accession":"0000950170-24-025902","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-025902","line_url":"/filing/0000950170-24-025902#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":605.0,"shares_display":"605","price_per_share":32.99,"price_display":"32.99","price_state":"stated","total_value":19958.95,"total_display":"19,958.95","total_whole":"19,959","shares_owned_after":71470.0,"shares_owned_after_display":"71,470","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-04","filed_date":"2024-03-05","scope":"insider"},{"id":2892163,"accession":"0000950170-24-002502","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-002502","line_url":"/filing/0000950170-24-002502","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4608.0,"shares_display":"4,608","price_per_share":29.503971354166666,"price_display":"29.50","price_state":"stated","total_value":135954.3,"total_display":"135,954.30","total_whole":"135,954","shares_owned_after":40845.0,"shares_owned_after_display":"40,845","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider","n_lines":2},{"id":7835894,"accession":"0001209191-23-041495","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-041495","line_url":"/filing/0001209191-23-041495#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360.0,"shares_display":"360","price_per_share":40.51,"price_display":"40.51","price_state":"stated","total_value":14583.6,"total_display":"14,583.60","total_whole":"14,584","shares_owned_after":45146.0,"shares_owned_after_display":"45,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-06","scope":"insider"},{"id":7922606,"accession":"0001209191-23-039148","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-039148","line_url":"/filing/0001209191-23-039148#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":225000.0,"total_display":"225,000.00","total_whole":"225,000","shares_owned_after":45146.0,"shares_owned_after_display":"45,146","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-20","filed_date":"2023-06-22","scope":"insider"},{"id":7895758,"accession":"0001209191-23-002412","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-002412","line_url":"/filing/0001209191-23-002412#line-3","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1692.0,"shares_display":"1,692","price_per_share":37.21,"price_display":"37.21","price_state":"stated","total_value":62959.32,"total_display":"62,959.32","total_whole":"62,959","shares_owned_after":14473.0,"shares_owned_after_display":"14,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":7895756,"accession":"0001209191-23-002412","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002412","line_url":"/filing/0001209191-23-002412#line-2","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":231.0,"shares_display":"231","price_per_share":34.48,"price_display":"34.48","price_state":"stated","total_value":7964.88,"total_display":"7,964.88","total_whole":"7,965","shares_owned_after":16165.0,"shares_owned_after_display":"16,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-06","scope":"insider"},{"id":7895754,"accession":"0001209191-23-002412","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-002412","line_url":"/filing/0001209191-23-002412#line-1","is_derivative":false,"issuer_cik":"0001652130","issuer_name":"Intellia Therapeutics, Inc.","issuer_ticker":"NTLA","issuer_name_source":null,"issuer_url":"/issuer/0001652130","owner_cik":"0001914448","owner_name":"Clark Eliana","owner_display_name":"Clark Eliana","owner_url":"/insider/0001914448","role":"Officer (EVP, Chief Technical Officer)","role_mark":"O","role_mark_label":"Officer (EVP, Chief Technical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, Chief Technical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":105.0,"shares_display":"105","price_per_share":51.74,"price_display":"51.74","price_state":"stated","total_value":5432.7,"total_display":"5,432.70","total_whole":"5,433","shares_owned_after":16165.0,"shares_owned_after_display":"16,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2023-01-06","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":15,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001652130","name":"Intellia Therapeutics, Inc.","url":"/issuer/0001652130","role":"Officer (EVP, Chief Technical Officer)","n_filings":11,"first_seen":"2023-01-06","last_seen":"2026-03-03"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001914448","retrieved_at":"2026-08-24T18:02:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}